Michael F. Leahy

Improved outcomes and reduced costs associated with a health‐system–wide patient blood management program: a retrospective observational study in four major adult tertiary‐care hospitals

Michael F. Leahy, Axel Hofmann, Simon Towler et al. · Transfusion · 2017 · 418 citations · Full text

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

Timothy P. Hughes, Susan Branford, Deborah L. White et al. · Blood · 2008 · 177 citations · Full text

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

A pragmatic approach to embedding patient blood management in a tertiary hospital

Michael F. Leahy, Heather Roberts, Syed Aqif Mukhtar et al. · Transfusion · 2013 · 96 citations

Multicenter Phase II Clinical Study of Iodine-131–Rituximab Radioimmunotherapy in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma

Michael F. Leahy, John F. Seymour, Rodney J. Hicks et al. · Journal of Clinical Oncology · 2006 · 92 citations · Full text